Abstract
The pancreas plays an important role in our body to help with maintaining and regulating homeostatic conditions. One of the cellular pathways that play a major role in pancreatic cell growth and division is the phosphatidylinositol-3-kinase-AKT pathway. According to current research studies, even the smallest changes to the phosphatidylinositol-3-kinase-AKT can cause abnormal cellular growth leading to the development of cancerous cells. Currently, there are many treatment options which are targeting the PI3K-AKT signaling pathway. This chapter examines the function of phosphatidylinositol-3-kinase-AKT pathway in pancreatic cancer and discusses current research studies that focus on potential treatment options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
What Causes Pancreatic Cancer? (n.d.) Retrieved October 13, 2017, from https://www.cancer.org/cancer/pancreatic-cancer/causes-risks-prevention/what-causes.html
Osaki M, Oshimura M, Ito H (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9(6):667–676. https://doi.org/10.1023/b:appt.0000045801.15585.dd
Mao Y, Xi L, Li Q, Cai Z, Lai Y, Zhang X, Yu C (2016) Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Oncol Rep 36(1):49–56. https://doi.org/10.3892/or.2016.4820
Chen L, Li Z, Ahmad N, Liu X (2015) Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation. Biochemistry 54:2473–2480. https://doi.org/10.1021/acs.biochem.5b00016
Wang S, Wu X, Zhang J, Chen Y, Xu J, Xia X, He S, Qiang F, Li A, Shu Y et al (2013) CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer. Gut 62:496–508. https://doi.org/10.1136/gutjnl-2011-301522
Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, Tsang BK, Cheng JQ (2004) Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279:5405–5412. https://doi.org/10.1074/jbc.M312044200
Baer R, Cintas C, Therville N, Guillermet-Guibert J (2015) Implication of PI3K/Akt pathway in pancreatic cancer: when PI3K isoforms matter? Adv Biol Regul 59:19–35. https://doi.org/10.1016/j.jbior.2015.05.001
Bowles T, Parsons C, Muilenburg D, Bold R (2009) Targeted inhibition of AKT in pancreatic cancer. Curr Cancer Ther Rev 5(4):288–295. https://doi.org/10.2174/157339409789712654
Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol 4:64. https://doi.org/10.3389/fonc.2014.00064
Kornmann M, Beger HG, Korc M (1998) Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 17(2):169–175. https://doi.org/10.1097/00006676-199808000-00010
Agbunag C, Bar-Sagi D (2004) Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer Res 64(16):5659–5663. https://doi.org/10.1158/0008-5472.can-04-0807
Matsumoto J, Kaneda M, Tada M, Hamada J, Okushiba S, Kondo S, Moriuchi T (2002) Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells. Jpn J Cancer Res 93(12):1317–1326. https://doi.org/10.1111/j.1349-7006.2002.tb01240.x
Leake K, Singhal J, Nagaprashantha LD, Awasthi S, Singhal SS (2012) RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic Cancer. PLoS One 7(4):e34582. https://doi.org/10.1371/journal.pone.0034582
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Momin, S., Nagaraju, G.P. (2018). PIK3-AKT and Its Role in Pancreatic Cancer. In: Nagaraju, G. (eds) Role of Tyrosine Kinases in Gastrointestinal Malignancies. Springer, Singapore. https://doi.org/10.1007/978-981-13-1486-5_4
Download citation
DOI: https://doi.org/10.1007/978-981-13-1486-5_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1485-8
Online ISBN: 978-981-13-1486-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)